International Journal of Obstetric Anesthesia
Volume 16, Issue 2 , Pages 155-159 , April 2007

Caesarean section using total intravenous anaesthesia in a patient with Ebstein’s anomaly complicated by supraventricular tachycardia

  • A.J.R. Macfarlane
    • ,
  • S. Moise
    • ,
  • D. Smith

      Affiliations

    • Corresponding Author InformationCorrespondence to: Dr Drew Smith, Department of Anaesthesia, Glasgow Royal Infirmary, 84 Castle Street, Glasgow, G4 0SF UK. Tel.: +0141 211 4620.

,Accepted 1 July 2006.

References 

  1. Lovell AT. Anaesthetic implications of grown-up congenital heart disease. Br J Anaesth. 2004;93:129–139
  2. Park MK. Cyanotic congenital heart defects. In:  Park MK editors. Pediatric Cardiology for Practitioners. St Louis: Mosby, Inc.; 2002;p. 218–223
  3. Ebstein W. Uber einen sehr seltenen Fall von Insufficienz der Valvula tricuspidalis, bedingt durch eine angeborene hochgradige Missbildung derselben. Archiv für Anatomie, Physiologie und wissenschaftliche Medicin. 1866;33:238–254
  4. Giuliani ER, Fuster V, Brandenburg RO, Mair DD. Ebstein’s anomaly. The clinical features and natural history of Ebstein’s anomaly of the tricuspid valve. Mayo Clin Proc. 1979;54:163–173
  5. Khositseth A, Danielson GK, Dearani JA, Munger TM, Porter CJ. Supraventricular tachyarrhythmias in Ebstein anomaly: Management and outcome. J Thorac Cardiovasc Surg. 2004;128:826–833
  6. Wu JC, Child JS. Common congenital heart disorders in adults. Curr Probl Cardiol. 2004;29:641–700
  7. Radford DJ, Graff RF, Neilson GH. Diagnosis and natural history of Ebstein’s anomaly. Br Heart J. 1985;54:517–522
  8. Connolly HM, Warnes CA. Ebstein’s anomaly: outcome of pregnancy. J Am Coll Cardiol. 1994;23:1194–1198
  9. Donnelly JE, Brown JM, Radford DJ. Pregnancy outcome and Ebstein’s anomaly. Br Heart J. 1991;66:368–371
  10. Lee SH, Chen SA, Wu TJ, et al. Effects of pregnancy on first onset and symptoms of paroxysmal supraventricular tachycardia. Am J Cardiol. 1995;76:675–678
  11. Blomstrom-Lundqvist C, Scheinman MM, Aliot EM, et al. American College of Cardiology/American Heart Association/European Society of Cardiology Guidelines for the Management of Patients with Supraventricular Arrhythmias. J Am Coll Cardiol. 2003;42:1493–1531
  12. Head CEG, Thorne SA. Congenital heart disease in pregnancy. Postgrad Med J. 2005;81:292–298
  13. Bonow RO, Carabello B, de Leon AC, et al. Guidelines for the management of patients with valvular heart disease. Executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease). Circulation. 1998;98:1949–1984
  14. Dob DP, Yentis SM. Practical management of the parturient with congenital heart disease. Int J Obstet Anesth. 2006;15:137–144
  15. Linter SP, Clarke K. Caesarean section under extradural analgesia in a patient with Ebstein’s anomaly. Br J Anaesth. 1984;56:203–205
  16. Halpern S, Gidwaney A, Gates B. Anaesthesia for caesarean section in a pre-eclamptic patient with Ebstein’s anomaly. Can Anaesth Soc J. 1985;32:244–247
  17. Van de Velde M, Teunkens A, Kuypers M, Dewinter T, Vandermeersch E. General anaesthesia with target controlled infusion of propofol for planned caesarean section: maternal and neonatal effects of a remifentanil-based technique. Int J Obstet Anesth. 2004;13:153–158
  18. Beers R, Camporesi E. Remifentanil update: clinical science and utility. CNS Drugs. 2004;18:1085–1104
  19. Bedard JM, Richardson MG, Wissler RN. General anesthesia with remifentanil for Cesarean section in a parturient with an acoustic neuroma. Can J Anaesth. 1999;46:576–580
  20. Imarengiaye C, Littleford J, Davies S, Thapar K, Kingdom J. Goal oriented general anesthesia for Cesarean section in a parturient with a large intracranial epidermoid cyst. Can J Anaesth. 2001;48:884–889
  21. Wadsworth R, Greer R, MacDonald JMS, Vohra A. The use of remifentanil during general anaesthesia for caesarean delivery in two patients with severe heart dysfunction. Int J Obstet Anesth. 2002;11:38–43
  22. Johannsen EK, Munro AJ. Remifentanil in emergency caesarean section in pre-eclampsia complicated by thrombocytopenia and abnormal liver function. Anaesth Intensive Care. 1999;27:527–529
  23. Mertens E, Saldien V, Coppejans H, Bettens K, Vercauteren M. Target-controlled infusion of remifentanil and propofol for cesarean section in a patient with multivalvular disease and severe pulmonary hypertension. Acta Anaesthesiol Belg. 2001;52:207–209
  24. Carvalho B, Mirikitani EJ, Lyell D, Evans DA, Druzin M, Riley ET. Neonatal chest wall rigidity following the use of remifentanil for caesarean delivery in a patient with autoimmune hepatitis and thrombocytopenia. Int J Obstet Anesth. 2004;13:53–56
  25. Scott H, Bateman C, Price M. The use of remifentanil in general anaesthesia for Caesarean section in a patient with mitral valve disease. Anaesthesia. 1998;53:695–697
  26. McCarroll CP, Paxton LD, Elliott P, Wilson DB. Use of remifentanil in a patient with peripartum cardiomyopathy requiring Caesarean section. Br J Anaesth. 2001;86:135–138
  27. Mertens MJ, Olofsen E, Engbers FH, et al. Propofol reduces perioperative remifentanil requirements in a synergistic manner: response surface modeling of perioperative remifentanil–propofol interactions. Anesthesiology. 2003;99:347–359

PII: S0959-289X(06)00165-8

doi: 10.1016/j.ijoa.2006.07.009

International Journal of Obstetric Anesthesia
Volume 16, Issue 2 , Pages 155-159 , April 2007

Article Tools